Brief by Shorts91 Newsdesk / 06:05pm on 02 Dec 2024,Monday India
Gordon Sanghera, CEO of Oxford Nanopore Technologies, has spearheaded a landmark UK partnership to create the world’s first comprehensive "epigenetic map" of the human genome. The project, involving the UK Biobank, NHS England, and Genomics England, will analyze 50,000 samples to advance research on diseases like cancer and dementia. Sanghera, of Punjabi descent, emphasized the transformative potential of epigenetics in developing targeted treatments. UK officials highlighted the initiative’s role in the government’s 10-year health plan, which aims to prioritize prevention. The dataset promises to enhance understanding of disease progression and revolutionize healthcare globally.
